![[1,2,4]TRIAZOLO[1,5-A]PYRIDINE COMPOUND AS JAK INHIBITOR AND USE THEREOF](/docs/US/2021-05-27/US20210155621A1/abs.jpg.600x600.jpg)
- 专利标题： [1,2,4]TRIAZOLO[1,5-A]PYRIDINE COMPOUND AS JAK INHIBITOR AND USE THEREOF
-
申请号： US17263416申请日： 2019-08-23
-
公开(公告)号： US20210155621A1公开(公告)日： 2021-05-27
- 发明人: Weiwei MAO , Wenyuan QIAN , Xuejian ZHENG , Guoping HU , Changqing WEI , Jian LI , Shuhui CHEN
- 申请人： Zhuhai United Laboratories Co., Ltd.
- 申请人地址： CN Jinwan District Zhuhai, Guangdong
- 专利权人： Zhuhai United Laboratories Co., Ltd.
- 当前专利权人： Zhuhai United Laboratories Co., Ltd.
- 当前专利权人地址： CN Jinwan District Zhuhai, Guangdong
- 优先权： CN201810968207.6 20180823
- 国际申请： PCT/CN2019/102209 WO 20190823
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61P19/02
![[1,2,4]TRIAZOLO[1,5-A]PYRIDINE COMPOUND AS JAK INHIBITOR AND USE THEREOF](/abs-image/US/2021/05/27/US20210155621A1/abs.jpg.150x150.jpg)
摘要：
Disclosed are a [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and an application thereof in preparing a drug for treating a disease related to JAK or/and TYK2. Specifically, the present invention relates to a compound represented by formula (I), or an isomer or pharmaceutically acceptable salt thereof. (I)
公开/授权文献
信息查询
